Performance analysis of Kyverna Therapeutics (KYTX)
Annual Return
Since Feb 8, 2024, KYTX has had an average annual return of -43.29%, underperforming the benchmark SPY, which returned +19.49% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -20.43% | +151.24% | -87.53% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.78% | +2.51% | +5.12% | +1.95% | -3.17% | +4.58% | -16.06% | -20.43% | |||||
| 2025 | -13.39% | -12.31% | -32.10% | +19.75% | +10.39% | +20.35% | +16.32% | +3.95% | +61.68% | +16.15% | +10.07% | +22.53% | +151.24% |
| 2024 | -9.43% | -8.58% | -39.05% | -17.24% | -40.15% | +15.48% | -7.27% | -39.11% | -2.27% | +20.72% | -35.15% | -87.53% |
Drawdown analysis of Kyverna Therapeutics (KYTX)
The maximum drawdown for the KYTX was -93.92%, occurring on Apr 16, 2025. This drawdown has not yet recovered.
The current KYTX drawdown is -75.15%.
Since Feb 8, 2024 KYTX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -93.92% | Feb 9, 2024 | 296 | Apr 16, 2025 | Ongoing | Ongoing | Ongoing |